The US Biotechnology Market Outlook to 2016
Future Growth Led by Surging Biotech Application in Agriculture, Health and Industrial Sector
November 2012
111
About the Report
About the Report
- The market size of the US Biotechnology Market by revenue for the period 2006-2011.
- Market segmentation of the US biotechnology market on the basis of bio-pharmaceuticals, agricultural biotechnology and industrial, 2006-2011.
- Market size, introduction and future outlook/projections of the US bio-pharmaceutical market.
- Company Profiles of major companies in the US bio-phrmaceuticals market.
- Market size, introduction and future outlook/projections of the US agriculture biotechnology market.
- Market segmentation of the US agricultural biotechnology market on the basis of biotech crops and bio-pesticides.
- Market size, introduction and future outlook/projections of the biotech crops and bio-pesticides market of the US.
- Trends and Development of the US agricultural biotechnology market.
- Company Profiles of major companies in the US agricultural biotechnology market.
- Market segmentation of the US industrial biotechnology market on the basis of biofuels and bio-enzymes.
- Market size, introduction and future outlook/projections of the biofuels and bio-enzymes market of the US.
- Trends and Development of the US industrial biotechnology market.
- Company Profiles of major companies in the US bio-enzymes market.
- Future outlook and projections of the US biotechnology market, 2012-2016.
Products
Products
biotech industry, biopharmaceuticals, biopesticides and bioseeds, biofuel and bioenzymes, Biologic
Companies
Pfizer, Merck & Co, Novartis, AstraZeneca, GlaxoSmithKline, Monsanto, Syngenta, BASF, Dow AgroSciences, Bayer AG, NOVOZYMES, GENENCOR
Table of Contents
Table of Contents
1. The US Biotechnology Market Introduction
2. The US Biotechnology Market Size by Revenue, 2006-2011
3. The US Biotechnology Market Segmentation By Application, 2006-2011
3.1. The US Bio-Pharmaceutical/Biologics Market Size and Introduction, 2006-2011
3.1.1. Top Selling Biologic Drugs, 2010
3.1.2. The US Bio-Pharmaceuticals Market Trends And Developments
Bio-Pharmaceutical Companies Focus on Outsourcing as Short Term Strategy
High Approvals Increasing the Number of Bio-Pharmaceutical Products
3.1.3. Top US Biopharmaceutical Companies Market Share, 2011
3.1.4. Biologic Drugs Future Projections, 2012-2016
3.1.5. Major Bio-Pharmaceutical Company Profiles
3.1.5.1. Pfizer Inc
Company Overview
Business Strategies
Financial Performance
3.1.5.2. Merck & Co
Company Overview
Business Strategies
Financial Performance
3.1.5.3. Novartis
Company Overview
Business Strategies
Financial Performance
3.1.5.4. AstraZeneca
Company Overview
Business Strategies
Financial Performance
3.1.5.5. GlaxoSmithKline
Company Overvie
Business Strategies
Financial Performance
3.1.6. Macro Economic and Industry Indicators: Current and Projections
3.1.6.1. Population, 2005-2015
3.1.6.2. Inpatient Admissions & Outpatients Visits, 2005-2010
3.1.6.3. Number of People with Health Insurance, 2005-2010
3.1.6.4. Prescription Drug Price index, 2005-2015
3.1.6.5. Personal Disposable Income, 2005-2015
3.2. The US Agricultural Biotechnology Market Size and Introduction 2006-2011
3.2.1. The US Agricultural Biotechnology Market Segmentation, 2006-2011
3.2.2. The US Biotechnology Crop Market Size, 2006-2011
3.2.2.1. By Crop Area, 2006-2011
3.2.2.2. By Revenue, 2006-2011
3.2.3. The US Biotechnology Crop Market Future Outlook/Projections, 2012-2016
3.2.3.1. By Crop Area and Revenue, 2012-2016
3.2.4. The US Bio-Pesticides Market Size and Introduction, 2006-2011
3.2.5. The US Bio-Pesticides Market Future Outlook and Projections, 2012-2016
3.2.6. The US Agriculture Biotechnology Market Trends and Developments
Labeling of GM Food in The US Market
The US Supermarkets Selling Privately Labeled Organic Products
3.2.7. The US Agricultural Biotechnology Future Outlook and Projections 2012-2016
3.2.8. Company Profiles of Major Companies in the US Agricultural Biotechnology Market
3.3. The US Industrial Biotechnology Market Size and Introduction 2006-2011
3.3.1. The US Industrial Biotechnology Market Segmentation, 2006-2011
3.3.2. The US Biofuel Market Size by Revenue, 2006-2011
3.3.2.1. The US Biofuel Market Size by Production and Consumption, 2005-2011
3.3.2.2. The US Fuel Ethanol Import, 2005-2011
3.3.2.3. The US Bio Diesel Import and Export, 2005-2011
3.3.3. The US Biofuel Market Segmentation, 2006-2011
3.3.3.1. By Fuel Ethanol and Bio Diesel, 2006-2011
3.3.4. The US Biofuel Industry Future Projections, 2012-2016
3.3.4.1. By Value, 2012-2016
3.3.4.2. By Fuel Ethanol and Bio Diesel, 2012-2016
3.3.5. The US Bio-Enzymes Market Size by Revenue, 2006-2011
3.3.6. Company Profiles of Major Companies in US Bio-Enzymes Market, 2011
3.3.6.1. Novozymes
Company Overview
Business Strategies
Financial Performance
3.3.6.2. Genencor
Company Overview
Business Strategies
Financial Performance
3.3.7. The US Bio-Enzymes Market Future Outlook and Projections, 2012-2016
3.3.8. The US Industrial Biotechnology Market Trends And Developments
Increasing Government Blending Rate Targets
Shifting Focus Towards Advanced Biofuels
Growing Application of Industrial Enzymes For Biofuels
3.3.9. The US Industrial Biotechnology Future Outlook and Projections, 2012-2016
4. The US Biotechnology Market Future Outlook and Projections
4.1. Cause and Effect Relationship Between Industry Factors and The US Biotechnology Industry
5. Appendix
5.1. Market Definitions
5.2. Abbreviations
5.3. Research Methodology
Data Collection Methods
Approach
Variables (Dependent and Independent)
Multi Factor Based Sensitivity Model
Scenario Analysis
Final Conclusion
5.4. Disclaimer
List of Figure
Figure 1: US Biotechnology Market Size in USD Million, 2006-2011
Figure 2: The US Biotechnology Market Segmentation by Bio-Pharmaceuticals,Agriculture Biotech and Industrial Biotechnology in Percentage, 2006-2011
Figure 3: The US Biopharmaceuticals Market Size by Revenue in USD Billion, 2006-2011
Figure 4: Market Share of the Major Biopharmaceutical Companies in the US on the Basis of Revenue, Percentage, 2011
Figure 5: Future Projections of the US Biologic Drug Sales in USD Billion, 2012-2016
Figure 6: Pfizer Biopharmaceutical Sales in the US in USD Billion, 2005-2011
Figure 7: Merck Pharmaceutical Drugs Sales in the US in USD Billion, 2009-2011
Figure 8: Novartis Drug Revenue in the US in USD Billion, 2005-2011
Figure 9: AstraZeneca Pharmaceutical Drug Sales in USD Billion, 2005-2011
Figure 10: GlaxoSmithKline Pharmaceutical Drug Sales in the US in USD Billion, 2007-2011
Figure 11: The US Population in Million, 2005-2015
Figure 12: Inpatient Admissions in Community Hospitals in the US in Million, 2005-2010
Figure 13: Outpatient Visits in Community Hospitals in the US in Million, 2005-2010
Figure 14: Total Number of People in the US with Health Insurance in Million, 2005-2010
Figure 15: The US Prescription Drug Price Index, 2005-2015
Figure 16: Personal Disposable Income in the US in USD Billion, 2005-2015
Figure 17: The US Agriculture Biotechnology Market Size in USD Million, 2006-2011
Figure 18: The US Agriculture Biotechnology Market Segmentation by Biotech Crops and Bio-Pesticides, 2006-2011
Figure 19: The US Biotechnology Crop Market Size in Million Hectares, 2006-2011
Figure 20: The US Biotechnology Crop Market Size in USD Million, 2006-2011
Figure 21: The US Biotechnology Crop Market Size in Million Hectares and USD Million, 2012-2016
Figure 22: The US Bio-Pesticides Market Size in USD Million, 2006-2011
Figure 23: The US Bio-Pesticides Market Size in USD Million, 2012-2016
Figure 24: The US Agricultural Biotechnology Market Size in USD Million, 2012-2016
Figure 25: The US Industrial Biotechnology Market Size in USD Million, 2006-2011
Figure 26: The US Industrial Biotechnology Market Segmentation in Percentage, 2006-2011
Figure 27: The US Biofuel Market Size on the Basis of Revenue in USD Million, 2006-2011
Figure 28: The US Biofuel Market Size on the Basis of Production, in Thousands Barrel per Day, 2005-2011
Figure 29: The US Biofuel Market Size on the Basis of Consumption, in Thousands Barrel Per Day, 2005-2011
Figure 30: The US Fuel Ethanol Import in Thousand Barrels from 2005-2011 and Export in Thousands Barrels per Year, 2010 and 2011
Figure 31: The US Bio Diesel Import and Export, in Thousands Barrels per Year, 2006-2011
Figure 32: The US Bio Diesel Lifecycle
Figure 33: The US Biofuel Market Segmentation by Fuel Ethanol and Bio Diesel on the Basis of Production in Thousands Barrels per Day, 2006-2011
Figure 34: The US Biofuel Market Segmentation by Fuel Ethanol and Bio Diesel on the Basis of Consumption in Thousands Barrels per Day, 2006-2011
Figure 35: The US Biofuel Market Projections by Revenue in USD Million, 2012-2016
Figure 36: The US Bio Enzymes Market Size in USD Million, 2006-2011
Figure 37: Market share of Major Companies in the US Enzymes Market, 2011
Figure 38: Novozymes Total Sales in USD Million, 2007-2011
Figure 39: Novozymes R&D Costs in USD Million, 2007-2011
Figure 40: The US Bio-Enzymes Market Size in USD Million, 2012-2016
Figure 41: The US Industrial Biotechnology Market Size in USD Million, 2012-2016
Figure 42: The US Biotechnology Market Size in USD Million, 2012-2016
?
List of Table
Table 1: The US Sales of Top Selling Global Biologic Drugs, USD billion, 2010
Table 2 : Bio-Pharmaceutical Products Approved By FDA in 2010 (until mid September)
Table 3: Leading Biopharmaceutical Companies in the US by Sales in USD Billion, 2011
Table 4: Pfizer's Product Patent Expiration Year
Table 5: Top Selling Pfizer's Biopharmaceutical Products in the US in USD Million, and their Revenue Contribution in Percentage, 2011
Table 6: Merck's Top Pharmaceutical Drug Sales in the US in USD Million, 2010-2011
Table 7: Novartis' Revenue Segmentation by Pharmaceutical and Sandoz Division in the US in USD Billion, 2005 - 2011
Table 8: Novartis' Top Pharmaceutical Drug Sales in the US in USD Million, 2011
Table 9: Astra Zeneca's Pharmaceutical Drug Sales in the US by Product and Therapeutic Category in USD Million, 2011
Table 10: GlaxoSmithKline's Top Selling Pharmaceutical Drugs in the US in USD Million, 2011
Table 11: Demographic Distribution of Population in US on the basis of Age, in Million, 2009-2012
Table 12: Company Profile of Major Companies in the US Agricultural Biotechnology, 2011
Table 13: The US Biofuel Market Segmentation by Fuel Ethanol and Bio Diesel on the Basis of Production and Consumption in Thousands Barrels per Day, 2012-2016
Table 14: Cause and Effect Relationship Analysis between Industry Factors and Expected Industry Prospects of the US Biotechnology Industry
Table 15: Correlation Matrix
Table 16: Regression Coefficients Output
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.